In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene Drug Master File in Korea (7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene. The MFDS reviews the 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene KDMF as part of the drug registration process and uses the information provided in the 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene KDMF to evaluate the safety and efficacy of the drug.
After submitting a 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0?,?]trideca-2(6),4,7,10,12-pentaene suppliers with KDMF on PharmaCompass.